Finance

Lists
Why is SBS down 2,15%?
Dive Deeper
SBS:FRA
Stratec SE
€20,50
-2,15%
(-0,45) 1D
6 ຕ.ລ., 22 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
€20,50
High
€20,50
Low
€20,50
Mkt. cap
258,16 ລ້ານ
Avg. vol.
46,00
Volume
0,00
Dividend
2,93%
Quarterly dividend
€0,15
Ex-dividend date
24 ມິ.ຖ. 2026
52-wk high
€32,20
52-wk low
€16,38
EPS
€-0,03
Shares outstanding
11,96 ລ້ານ
No. of employees
1 ພັນ
Open
€20,50
High
€20,50
Low
€20,50
Mkt. cap
258,16 ລ້ານ
Avg. vol.
46,00
Volume
0,00
Dividend
2,93%
Quarterly dividend
€0,15
Ex-dividend date
24 ມິ.ຖ. 2026
52-wk high
€32,20
52-wk low
€16,38
EPS
€-0,03
Shares outstanding
11,96 ລ້ານ
No. of employees
1 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
14 ຊົ່ວໂມງກ່ອນ
mwb research downgrades Stratec stock from Hold to Sell
AD HOC NEWS
AD HOC NEWS
·
1 ມື້ກ່ອນ
mwb research downgrades Stratec stock to Sell
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1,38 ພັນ
Founded1979
Headquarters-
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
57,00 ລ້ານ
75,28 ລ້ານ
53,43 ລ້ານ
59,11 ລ້ານ
Cost of goods sold
43,70 ລ້ານ
56,31 ລ້ານ
43,22 ລ້ານ
43,87 ລ້ານ
Cost of revenue
43,70 ລ້ານ
56,31 ລ້ານ
43,22 ລ້ານ
43,87 ລ້ານ
Research and development expenses
1,59 ລ້ານ
2,78 ລ້ານ
1,72 ລ້ານ
1,49 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,47 ລ້ານ
10,82 ລ້ານ
8,82 ລ້ານ
9,64 ລ້ານ
Operating expense
9,78 ລ້ານ
11,19 ລ້ານ
10,30 ລ້ານ
9,66 ລ້ານ
Total operating expenses
53,48 ລ້ານ
67,50 ລ້ານ
53,53 ລ້ານ
53,54 ລ້ານ
Operating income
3,52 ລ້ານ
7,78 ລ້ານ
-104,00 ພັນ
5,57 ລ້ານ
Other non operating income
-117,00 ພັນ
219,00 ພັນ
-65,00 ພັນ
61,00 ພັນ
EBT including unusual items
2,38 ລ້ານ
-826,00 ພັນ
-1,16 ລ້ານ
5,43 ລ້ານ
EBT excluding unusual items
2,38 ລ້ານ
5,55 ລ້ານ
-1,16 ລ້ານ
5,43 ລ້ານ
Income tax expense
878,00 ພັນ
3,52 ລ້ານ
557,00 ພັນ
1,27 ລ້ານ
Effective tax rate
36,91%
-426,03%
-48,18%
23,35%
Other operating expenses
-274,00 ພັນ
-2,41 ລ້ານ
-235,00 ພັນ
-1,46 ລ້ານ
Net income
1,50 ລ້ານ
-4,34 ລ້ານ
-1,71 ລ້ານ
4,16 ລ້ານ
Net profit margin
2,63%
-5,77%
-3,21%
7,04%
Earnings per share
-
-
-
-
Interest and investment income
33,00 ພັນ
8,00 ພັນ
34,00 ພັນ
55,00 ພັນ
Interest expense
-1,06 ລ້ານ
-955,00 ພັນ
-1,02 ລ້ານ
-260,00 ພັນ
Net interest expenses
-1,02 ລ້ານ
-947,00 ພັນ
-987,00 ພັນ
-205,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
8,04 ລ້ານ
10,71 ລ້ານ
4,45 ລ້ານ
10,03 ລ້ານ
Gain or loss from assets sale
13,00 ພັນ
3,00 ພັນ
-94,00 ພັນ
-9,00 ພັນ
AI content may include mistakes. Learn more
ແອັບຂອງ Google